David Calkins, Ph.D., and his colleagues are testing p38 MAP kinase inhibitors, a class of drugs used to treat rheumatoid arthritis, to blunt the inflammatory response in the visual system.

Authors

• Person: Not available Organization: Vanderbilt University
  The Good, The Bad and the Ugly of Inflammation

Sources

• The Good, The Bad and the Ugly of Inflammation medschool.vanderbilt.edu Vanderbilt University via serper

Referenced by nodes (1)

• rheumatoid arthritis concept